✦ LIBER ✦

Clinical pharmacokinetics of procainamide infusions in relation to acetylator phenotype

✍ Scribed by John J. Lima; David R. Conti; Allen L. Goldfarb; William J. Tilstone; Lawrence H. Golden; William J. Jusko

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Significance of acetylator phenotype in

✍ P. Ylitalo; R. Ruosteenoja; O. Leskinen; T. Metsä-Ketelä 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 646 KB

Procainamide-Induced Lupus Erythematosus

✍ Sonnhag, C. ;Karlsson, E. ;Hed, J. 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) ⚖ 468 KB

Pharmacokinetics of hydralazine and its

✍ Danny D. Shen; James P. Hosler; Richard L. Schroder; Daniel L. Azarnoff 📂 Article 📅 1980 🏛 Springer 🌐 English ⚖ 942 KB

Distribution of acetylator phenotype in

✍ O. Paulsen; L. G. Nilsson 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 546 KB

Pharmacokinetics of tramadol enantiomers

✍ Emilio García-Quetglas; José Ramón Azanza; Belén Sádaba; María José Muñoz; Isabe 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 295 KB

P162 clinical pharmacokinetics of etopos

✍ Stremetzne, S.; Jaehde, U.; Beyer, J.; Steuer, J.; Siegert, W.; Schunack, W. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 135 KB